Higher circulating levels of C-reactive protein (CRP) – a non-specific marker of chronic inflammation – are associated with increased risks of breast cancer, but the epidemiological evidence for other inflammatory markers remains uncertain [2, 10, 11]. This evidence concerns the gene CRP and breast cancer.